CASIMERSEN

CASIMERSEN was reported 986 times

CASIMERSEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFLUENZA MYOCARDITIS 1 0.3333
1 CATHETER SITE DEHISCENCE 1 0.1111
2 CYSTATIN C INCREASED 4 0.0312
3 TENDON TRANSFER 1 0.0238
4 DUCHENNE MUSCULAR DYSTROPHY 2 0.0215
5 CATHETER SITE SCAB 2 0.0187
6 CATHETER SITE SCAR 1 0.0167
7 ANAL SPASM 1 0.0130
8 POOR VENOUS ACCESS 125 0.0121
9 SNAKE BITE 1 0.0100
10 STENOTROPHOMONAS SEPSIS 1 0.0083
11 CREATININE URINE ABNORMAL 1 0.0081
12 EXPOSURE TO SARS-COV-2 13 0.0076
13 TESTICULAR ABSCESS 1 0.0075
14 CATHETER SITE EXTRAVASATION 3 0.0075
15 VIRAL SEPSIS 1 0.0071
16 PATIENT UNCOOPERATIVE 3 0.0063
17 SENSORY PROCESSING DISORDER 1 0.0059
18 CATHETER SITE SWELLING 5 0.0053
19 VEIN RUPTURE 8 0.0048
20 ADULT FAILURE TO THRIVE 1 0.0047
21 INFUSION SITE SCAR 2 0.0045
22 PROCEDURAL ANXIETY 3 0.0044
23 CATHETER SITE PAIN 11 0.0042
24 CREATINE KINASE INCREASED 3 0.0039
25 CARDIO-RESPIRATORY DISTRESS 1 0.0035
26 CREATININE URINE INCREASED 1 0.0033
27 CATHETER SITE BRUISE 1 0.0030
28 CATHETER SITE IRRITATION 1 0.0030
29 INTENTIONAL DOSE OMISSION 81 0.0028
30 FAT EMBOLISM 1 0.0028
31 EXPOSURE TO COMMUNICABLE DISEASE 2 0.0027
32 ASYMPTOMATIC COVID-19 1 0.0025
33 NAIL BED DISORDER 1 0.0023
34 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
35 CENTRAL VENOUS CATHETERISATION 7 0.0023
36 PRODUCT DISTRIBUTION ISSUE 21 0.0023
37 CATHETER SITE RASH 1 0.0022
38 REFUSAL OF TREATMENT BY RELATIVE 1 0.0022
39 HEART TRANSPLANT 2 0.0022
40 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
41 INFUSION SITE DISCOMFORT 2 0.0019
42 INTERNAL FIXATION OF FRACTURE 1 0.0018
43 RECTAL ULCER 2 0.0017
44 GRUNTING 1 0.0017
45 BLOOD ELECTROLYTES ABNORMAL 2 0.0016
46 INFUSION SITE EXTRAVASATION 10 0.0016
47 PRODUCT TEMPERATURE EXCURSION ISSUE 8 0.0016
48 INFUSION SITE RASH 2 0.0015
49 URINE LEUKOCYTE ESTERASE POSITIVE 1 0.0014
50 OTITIS MEDIA ACUTE 1 0.0014
51 CATHETER SITE RELATED REACTION 1 0.0013
52 VEIN COLLAPSE 1 0.0013
53 FEAR OF FALLING 1 0.0012
54 GENITAL INFECTION FUNGAL 1 0.0012
55 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
56 INFECTED BITE 1 0.0012
57 LIP PRURITUS 1 0.0012
58 PRODUCT APPEARANCE CONFUSION 1 0.0011
59 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
60 DEVICE ISSUE 94 0.0010
61 NO ADVERSE EVENT 188 0.0010
62 SPUTUM RETENTION 1 0.0010
63 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
64 MUSCLE CONTRACTURE 2 0.0010
65 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
66 PRODUCT DOSE OMISSION ISSUE 282 0.0010
67 CATHETER SITE ERYTHEMA 2 0.0009
68 KETOSIS 1 0.0009
69 STREPTOCOCCAL BACTERAEMIA 1 0.0009
70 PRODUCT NAME CONFUSION 1 0.0009
71 CATHETER SITE DISCHARGE 1 0.0009
72 DEVICE DISPENSING ERROR 1 0.0008
73 PRODUCT PACKAGING CONFUSION 2 0.0008
74 CEREBRAL ARTERY EMBOLISM 1 0.0008
75 SCOLIOSIS 5 0.0008
76 NASAL PRURITUS 1 0.0008
77 RHINOVIRUS INFECTION 3 0.0008
78 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
79 INTERCEPTED PRODUCT PRESCRIBING ERROR 1 0.0008
80 RHONCHI 1 0.0007
81 ECHOCARDIOGRAM ABNORMAL 1 0.0007
82 DEVICE OCCLUSION 10 0.0007
83 TRACHEOSTOMY 1 0.0007
84 GENERALISED ANXIETY DISORDER 1 0.0007
85 SKIN STRIAE 1 0.0007
86 ATYPICAL PNEUMONIA 2 0.0007
87 MEAN CELL VOLUME DECREASED 1 0.0006
88 COSTOCHONDRITIS 1 0.0006
89 SHOULDER FRACTURE 1 0.0006
90 INTERCEPTED PRODUCT DISPENSING ERROR 1 0.0006
91 PROTEIN URINE PRESENT 3 0.0006
92 BLOOD CALCIUM ABNORMAL 1 0.0006
93 FLUID INTAKE REDUCED 3 0.0006
94 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
95 STREPTOCOCCAL INFECTION 3 0.0005
96 CATHETER SITE INFECTION 2 0.0005
97 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
98 DECUBITUS ULCER 4 0.0005
99 WALKING DISABILITY 1 0.0005
100 INFUSION SITE SWELLING 3 0.0005
101 DEVICE CONNECTION ISSUE 1 0.0005
102 INFUSION SITE BRUISING 1 0.0005
103 RENAL FUNCTION TEST ABNORMAL 2 0.0004
104 INFUSION SITE INFECTION 1 0.0004
105 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
106 PROTEINURIA 8 0.0004
107 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
108 PRODUCT SUPPLY ISSUE 3 0.0004
109 LOWER LIMB FRACTURE 8 0.0004
110 HAEMATOLOGICAL INFECTION 1 0.0004
111 BREATH SOUNDS ABNORMAL 2 0.0004
112 DEVICE INFUSION ISSUE 1 0.0004
113 FAILURE TO THRIVE 2 0.0004
114 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
115 COMPRESSION FRACTURE 2 0.0004
116 FRUSTRATION TOLERANCE DECREASED 3 0.0004
117 ACUTE RESPIRATORY FAILURE 7 0.0004
118 NECK MASS 1 0.0004
119 ADENOVIRUS INFECTION 1 0.0003
120 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
121 PRODUCT COMMUNICATION ISSUE 3 0.0003
122 ACNE CYSTIC 1 0.0003
123 INSURANCE ISSUE 5 0.0003
124 BLOOD CREATININE DECREASED 1 0.0003
125 PNEUMONIA VIRAL 1 0.0003
126 CUSHINGOID 1 0.0003
127 THROMBOSIS IN DEVICE 1 0.0003
128 PRODUCT PREPARATION ISSUE 2 0.0003
129 SUSPECTED COVID-19 1 0.0003
130 ILLNESS 31 0.0003
131 BRONCHIOLITIS 1 0.0003
132 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
133 DEVICE PLACEMENT ISSUE 1 0.0003
134 GASTROENTERITIS VIRAL 5 0.0003
135 DEVICE DISLOCATION 12 0.0003
136 GASTROENTERITIS 4 0.0003
137 THROAT CLEARING 1 0.0003
138 SNORING 1 0.0003
139 PRODUCT STORAGE ISSUE 1 0.0003
140 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
141 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
142 CONCUSSION 2 0.0003
143 BACTERAEMIA 3 0.0003
144 FUNGAL SKIN INFECTION 1 0.0002
145 SPINAL FUSION SURGERY 1 0.0002
146 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
147 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
148 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
149 INFUSION SITE PAIN 3 0.0002
150 PULMONARY FUNCTION TEST DECREASED 1 0.0002
151 PARONYCHIA 1 0.0002
152 ABDOMINAL ABSCESS 1 0.0002
153 WHEELCHAIR USER 1 0.0002
154 INFLUENZA 24 0.0002
155 TIBIA FRACTURE 1 0.0002
156 INCREASED APPETITE 4 0.0002
157 DEVICE RELATED INFECTION 3 0.0002
158 COVID-19 33 0.0002
159 INJECTION SITE DISCHARGE 1 0.0002
160 BEHAVIOUR DISORDER 1 0.0002
161 CHEILITIS 1 0.0002
162 PHARYNGITIS STREPTOCOCCAL 2 0.0002
163 TIC 1 0.0002
164 FAECALOMA 1 0.0002
165 AUTISM SPECTRUM DISORDER 1 0.0002
166 PERIORBITAL SWELLING 1 0.0002
167 NEPHROLITHIASIS 8 0.0002
168 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
169 PRODUCT LABEL CONFUSION 1 0.0002
170 HYPERCHLORHYDRIA 1 0.0002
171 GANGRENE 1 0.0002
172 NASAL DRYNESS 1 0.0002
173 BLOOD URINE PRESENT 3 0.0002
174 THERAPY CESSATION 8 0.0002
175 PROCTALGIA 1 0.0002
176 UNDERDOSE 11 0.0002
177 VIRAL INFECTION 5 0.0002
178 TERMINAL STATE 1 0.0001
179 SINUS CONGESTION 2 0.0001
180 WRONG PRODUCT ADMINISTERED 1 0.0001
181 POOR QUALITY SLEEP 3 0.0001
182 MYELODYSPLASTIC SYNDROME 2 0.0001
183 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
184 MAJOR DEPRESSION 1 0.0001
185 CARDIOMYOPATHY 2 0.0001
186 SUNBURN 1 0.0001
187 PYREXIA 46 0.0001
188 CHROMATURIA 3 0.0001
189 OSTEOPENIA 2 0.0001
190 TROPONIN INCREASED 1 0.0001
191 MUSCULOSKELETAL CHEST PAIN 2 0.0001
192 FEMUR FRACTURE 4 0.0001
193 DEHYDRATION 17 0.0001
194 CYANOSIS 2 0.0001
195 PNEUMOTHORAX 2 0.0001
196 BLOOD POTASSIUM INCREASED 2 0.0001
197 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
198 SPINAL COMPRESSION FRACTURE 1 0.0001
199 LIP SWELLING 4 0.0001
200 NASAL CONGESTION 7 0.0001
201 INFUSION SITE ERYTHEMA 1 0.0001
202 SCAR 2 0.0001
203 CARDIAC OPERATION 1 0.0001
204 GASTROINTESTINAL INFECTION 1 0.0001
205 MALAISE 48 0.0001
206 PNEUMONIA BACTERIAL 1 0.0001
207 OROPHARYNGEAL PAIN 10 0.0001
208 FLANK PAIN 1 0.0001
209 INFUSION RELATED REACTION 7 0.0001
210 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
211 AFFECT LABILITY 1 0.0001
212 ATELECTASIS 1 0.0001
213 THERAPY CHANGE 1 0.0001
214 LIGAMENT SPRAIN 1 0.0001
215 HEART RATE INCREASED 10 0.0001
216 BLOOD PRESSURE ABNORMAL 2 0.0001
217 RESPIRATORY DISORDER 3 0.0001
218 HYPOTONIA 1 0.0001
219 AGITATION 7 0.0001
220 PRODUCT DISPENSING ERROR 2 0.0001
221 ASPIRATION 1 0.0001
222 MALNUTRITION 1 0.0001
223 RASH PAPULAR 2 0.0001
224 CHOLECYSTECTOMY 1 0.0001
225 MYOCARDITIS 1 0.0001
226 PERICARDIAL EFFUSION 2 0.0001
227 CHOLECYSTITIS 1 0.0001
228 HYPERLIPIDAEMIA 1 0.0001
229 DIABETIC KETOACIDOSIS 2 0.0001
230 LOCALISED INFECTION 2 0.0001
231 ACCIDENTAL OVERDOSE 3 0.0001
232 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
233 GENERALISED OEDEMA 1 0.0001
234 CYST 1 0.0001
235 TOOTH EXTRACTION 1 0.0001
236 PNEUMONIA ASPIRATION 2 0.0001
237 UNRESPONSIVE TO STIMULI 2 0.0001
238 RHINORRHOEA 5 0.0001
239 RESPIRATORY TRACT INFECTION 2 0.0001
240 PULMONARY CONGESTION 1 0.0001
241 PERIPHERAL COLDNESS 1 0.0001
242 RESPIRATORY DISTRESS 2 0.0001
243 HYPOMAGNESAEMIA 1 0.0001
244 SEPSIS 8 0.0001
245 COUGH 20 0.0001
246 SEASONAL ALLERGY 1 0.0001
247 SINUS TACHYCARDIA 1 0.0001
248 BRONCHOSPASM 1 0.0001
249 ACCIDENTAL UNDERDOSE 1 0.0001
250 HYPERTHYROIDISM 1 0.0001
251 HYPOKINESIA 1 0.0001
252 APATHY 1 0.0001
253 WEIGHT INCREASED 15 0.0001
254 DEVICE FAILURE 1 0.0001
255 ANKLE FRACTURE 1 0.0001
256 RESPIRATORY TRACT CONGESTION 1 0.0001
257 HALLUCINATION, AUDITORY 1 0.0001
258 SCIATICA 1 0.0001
259 CARDIAC FAILURE 5 0.0001
260 MUSCLE TIGHTNESS 1 0.0001
261 SWELLING FACE 4 0.0001
262 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
263 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
264 HAEMATURIA 2 0.0001
265 MUSCULOSKELETAL DISCOMFORT 1 0.0001
266 DEVICE DEFECTIVE 1 0.0001
267 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
268 THERAPY INTERRUPTED 4 0.0001
269 CRYING 2 0.0001
270 BLOOD SODIUM DECREASED 1 0.0001
271 FOOT FRACTURE 1 0.0001
272 PNEUMONIA 17 0.0001
273 SLEEP APNOEA SYNDROME 1 0.0001
274 GLAUCOMA 1 0.0001
275 CHOKING 1 0.0001
276 SURGERY 3 0.0001
277 HAEMATOCRIT DECREASED 1 0.0001
278 UPPER LIMB FRACTURE 1 0.0001
279 SPINAL FRACTURE 1 0.0000
280 IRRITABILITY 3 0.0000
281 BONE MARROW FAILURE 1 0.0000
282 PRODUCT PREPARATION ERROR 1 0.0000
283 FALL 16 0.0000
284 ROAD TRAFFIC ACCIDENT 2 0.0000
285 RETCHING 1 0.0000
286 JOINT INJURY 1 0.0000
287 DEVICE LEAKAGE 2 0.0000
288 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
289 TRANSAMINASES INCREASED 1 0.0000
290 HEPATOTOXICITY 1 0.0000
291 THROMBOCYTOPENIA 5 0.0000
292 ORAL PAIN 1 0.0000
293 SNEEZING 1 0.0000
294 PRODUCT AVAILABILITY ISSUE 1 0.0000
295 NASOPHARYNGITIS 8 0.0000
296 CARDIAC DISORDER 4 0.0000
297 PRODUCT PRESCRIBING ERROR 1 0.0000
298 PRODUCTIVE COUGH 2 0.0000
299 ABDOMINAL DISCOMFORT 7 0.0000
300 CONTUSION 4 0.0000
301 MYALGIA 7 0.0000
302 PRESYNCOPE 1 0.0000
303 LIVER INJURY 1 0.0000
304 ENCEPHALOPATHY 1 0.0000
305 AGGRESSION 2 0.0000
306 ACNE 3 0.0000
307 HAEMATEMESIS 1 0.0000
308 INCORRECT DOSE ADMINISTERED 9 0.0000
309 SINUSITIS 4 0.0000
310 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
311 EAR INFECTION 1 0.0000
312 LIMB INJURY 1 0.0000
313 PALLOR 1 0.0000
314 MOOD ALTERED 1 0.0000
315 RESPIRATORY ARREST 1 0.0000
316 FEELING COLD 1 0.0000
317 PANCYTOPENIA 2 0.0000
318 PAIN IN JAW 1 0.0000
319 LETHARGY 2 0.0000
320 SEIZURE 4 0.0000
321 DYSSTASIA 1 0.0000
322 TACHYCARDIA 3 0.0000
323 GASTROINTESTINAL DISORDER 3 0.0000
324 BLOOD POTASSIUM DECREASED 1 0.0000
325 APHASIA 1 0.0000
326 DISCOMFORT 2 0.0000
327 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
328 EMOTIONAL DISORDER 1 0.0000
329 SWOLLEN TONGUE 1 0.0000
330 BONE DENSITY DECREASED 1 0.0000
331 DYSPHAGIA 3 0.0000
332 HEAD INJURY 1 0.0000
333 MIGRAINE 3 0.0000
334 MOOD SWINGS 1 0.0000
335 HIP FRACTURE 1 0.0000
336 ATRIAL FIBRILLATION 3 0.0000
337 STAPHYLOCOCCAL INFECTION 1 0.0000
338 BLOOD PRESSURE DECREASED 2 0.0000
339 EXPIRED PRODUCT ADMINISTERED 1 0.0000
340 FUNGAL INFECTION 1 0.0000
341 URINARY RETENTION 1 0.0000
342 GAIT INABILITY 1 0.0000
343 VOMITING 14 0.0000
344 HYPERKALAEMIA 1 0.0000
345 HYPOXIA 1 0.0000
346 SLEEP DISORDER 2 0.0000
347 PLATELET COUNT DECREASED 3 0.0000
348 RASH 12 0.0000
349 CHEST PAIN 5 0.0000
350 INTESTINAL OBSTRUCTION 1 0.0000
351 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
352 DECREASED APPETITE 6 0.0000
353 DISEASE PROGRESSION 3 0.0000
354 ABNORMAL BEHAVIOUR 1 0.0000
355 WEIGHT DECREASED 7 0.0000
356 HYPOTENSION 5 0.0000
357 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
358 EXTRA DOSE ADMINISTERED 1 0.0000
359 ABDOMINAL PAIN UPPER 5 0.0000
360 CARDIAC ARREST 2 0.0000
361 RHABDOMYOLYSIS 1 0.0000
362 RECTAL HAEMORRHAGE 1 0.0000
363 OVERDOSE 5 0.0000
364 SEPTIC SHOCK 1 0.0000
365 MENTAL DISORDER 1 0.0000
366 PULMONARY OEDEMA 1 0.0000
367 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
368 THROAT IRRITATION 1 0.0000
369 SUICIDAL IDEATION 2 0.0000
370 DIARRHOEA 14 0.0000
371 HYPOKALAEMIA 1 0.0000
372 RENAL DISORDER 1 0.0000
373 SWELLING 2 0.0000
374 ASTHENIA 8 0.0000
375 ANXIETY 6 0.0000
376 RASH ERYTHEMATOUS 1 0.0000
377 SOMNOLENCE 4 0.0000
378 CELLULITIS 1 0.0000
379 HAEMOGLOBIN DECREASED 2 0.0000
380 INFLAMMATION 1 0.0000
381 NERVOUSNESS 1 0.0000
382 ECZEMA 1 0.0000
383 INSOMNIA 5 0.0000
384 TREATMENT NONCOMPLIANCE 1 0.0000
385 NECK PAIN 1 0.0000
386 OXYGEN SATURATION DECREASED 1 0.0000
387 FLATULENCE 1 0.0000
388 MUSCULAR WEAKNESS 2 0.0000
389 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
390 ABDOMINAL PAIN 4 0.0000
391 WHEEZING 1 0.0000
392 CATARACT 1 0.0000
393 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
394 STOMATITIS 1 0.0000
395 MUSCLE SPASMS 3 0.0000
396 FEELING HOT 1 0.0000
397 NAUSEA 12 0.0000
398 HEPATIC ENZYME INCREASED 1 0.0000
399 ERYTHEMA 3 0.0000
400 HEADACHE 9 0.0000
401 INJURY 1 0.0000
402 RESPIRATORY FAILURE 1 0.0000
403 EPISTAXIS 1 0.0000
404 UNEVALUABLE EVENT 1 0.0000
405 DEPRESSION 3 0.0000
406 BLOOD PRESSURE INCREASED 2 0.0000
407 ACUTE KIDNEY INJURY 2 0.0000
408 PAIN 8 0.0000
409 RENAL IMPAIRMENT 1 0.0000
410 CEREBROVASCULAR ACCIDENT 2 0.0000
411 URINARY TRACT INFECTION 2 0.0000
412 FATIGUE 9 0.0000
413 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
414 MUSCULOSKELETAL STIFFNESS 1 0.0000
415 DYSPNOEA 6 0.0000
416 PULMONARY EMBOLISM 1 0.0000
417 GAIT DISTURBANCE 2 0.0000
418 DYSPEPSIA 1 0.0000
419 DIZZINESS 5 0.0000
420 FLUSHING 1 0.0000
421 CHEST DISCOMFORT 1 0.0000
422 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
423 CONSTIPATION 2 0.0000
424 PALPITATIONS 1 0.0000
425 FEELING ABNORMAL 2 0.0000
426 EMOTIONAL DISTRESS 1 0.0000
427 OEDEMA PERIPHERAL 1 0.0000
428 LOSS OF CONSCIOUSNESS 1 0.0000
429 RENAL FAILURE 1 0.0000
430 DEATH 6 0.0000
431 INFECTION 1 0.0000
432 PAIN IN EXTREMITY 2 0.0000
433 PERIPHERAL SWELLING 1 0.0000
434 PARAESTHESIA 1 0.0000
435 TOXICITY TO VARIOUS AGENTS 1 0.0000
436 HYPERSENSITIVITY 1 0.0000
437 BLOOD GLUCOSE INCREASED 1 0.0000
438 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
439 ARTHRALGIA 2 0.0000
440 HYPERTENSION 1 0.0000
441 CONDITION AGGRAVATED 1 0.0000
442 PRURITUS 1 0.0000
443 DRUG INEFFECTIVE 3 0.0000